Regeneron wins FDA approval for first gene therapy for genetic hearing loss - Reuters

Regeneron wins FDA approval for first gene therapy for genetic hearing loss  Reuters

New Gene Therapy Enables Children With a Rare Form of Deafness to Hear

The treatment, the first of its kind, was approved by the Food and Drug Administration on Thursday. “Our baby was born deaf, and now he can hear,” said one parent.

By Gina Kolata

First gene therapy for deafness approved by the FDA

The FDA has approved the first gene therapy that can restore hearing to people who were born with a rare form deafness.

By Rob Stein

Can gene therapy restore hearing in children with inherited deafness? What FDA approval means

FDA approves first gene therapy for inherited deafness, targeting OTOF mutations.

Regeneron wins FDA approval for hearing loss therapy

Researchers achieve breakthrough in gene therapy for congenital deafness - China Daily

Researchers achieve breakthrough in gene therapy for congenital deafness  China Daily